Protecting innovations leads to medtech success. Top Greenberg Traurig patent attorneys explain how. Roman Fayerberg and David J. Dykeman, Greenberg Traurig A strategic patent portfolio is key to a medtech company’s growth and success, but building a robust patent portfolio takes strategy, time and money. While there are no shortcuts to building a strategic patent […]
intellectual property
Medtronic, Tandem Diabetes Care bury the hatchet on potential IP disputes
Two major insulin pump makers — Medtronic (NYSE:MDT) and Tandem Diabetes Care (NSDQ:TNDM) — announced today that they’ve inked a non-exclusive patent cross-license agreement related to diabetes treatment tech. The companies said the agreement will allow them to focus on innovation while avoiding the distraction of potential legal disagreements. The deal could be but another example of […]
5 strategies to prevent medtech IP theft
Even as they rapidly innovate to fight the coronavirus pandemic, medtech companies need to stop IP theft. Here are the basics. David J. Dykeman, Greenberg Traurig Medtech companies are at the forefront of innovation, and that has never been more evident than in the industry’s response to COVID-19. The healthcare research and development (R&D) engine […]
Medtech product liability and IP: Here’s where it’s going
Greenberg Traurig is one of the largest law practices in the United States, with 2,100 attorneys serving clients in 41 offices in the U.S., Europe, Latin America, the Middle East and Asia. Medical Design & Outsourcing recently sought insights from some of the top lawyers at GT who are involved in medical device products liability […]
